Position in ACAD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,126,684
-$13,284,207 QoQ
Shares Held
140,462
-77.1% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. ACAD ranks #45 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in ACAD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,126,684 | 140,462 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,410,891 | 614,410 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,538,326 | 400,109 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,145,194 | 53,092 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,808,583 | 349,704 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,916,338 | 485,904 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,450,633 | 549,456 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,679,823 | 534,143 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $6,551,820 | 354,344 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,168,058 | 260,877 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,324,368 | 111,534 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,662,138 | 111,154 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,666,116 | 141,664 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,778,342 | 174,519 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,907,368 | 177,712 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,340,785 | 166,131 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,520,139 | 104,052 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $850,322 | 36,432 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $333,229 | 20,062 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $368,713 | 6,897 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $284,501 | 6,897 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $578,586 | 11,937 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $997,480 | 23,609 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||